基于慈心冥想的心理干预对抑郁症患者的干预研究

注册号:

Registration number:

ChiCTR2100044258 

最近更新日期:

Date of Last Refreshed on:

2021-08-30 18:09:19 

注册时间:

Date of Registration:

2021-03-12 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于慈心冥想的心理干预对抑郁症患者的干预研究

Public title:

A study on the psychological intervention based on loving-kindness meditation on patients with depressive disorder

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于慈心冥想的心理干预对抑郁症患者的干预研究

Scientific title:

A study on the intervention based on loving-kindness meditation on patients with depressive disorder

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陈沼桦 

研究负责人:

戴琴 

Applicant:

Zhaohua Chen 

Study leader:

Qin Dai 

申请注册联系人电话:

Applicant telephone:

+86 18781399547

研究负责人电话:

Study leader's
telephone:

+86 13452113607

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1575411301@qq.com

研究负责人电子邮件:

Study leader's E-mail:

daiqin101@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市沙坪坝高滩岩正街30号陆军军医大学

研究负责人通讯地址:

重庆市沙坪坝高滩岩正街30号

Applicant address:

30 Gaotanyan Main Street, Shapingba District, Chongqing, China

Study leader's address:

30 Gaotanyan Main Street, Shapingba District, Chongqing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

陆军军医大学

Applicant's institution:

Army Medical University

研究负责人所在单位:

陆军军医大学

Affiliation of the Leader:

Army Medical University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020第036-2

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

陆军军医大学医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Army Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-03-03 00:00:00

伦理委员会联系人:

张红军

Contact Name of the ethic committee:

Hongjun Zhang

伦理委员会联系地址:

重庆市沙坪坝高滩岩正街30号陆军军医大学

Contact Address of the ethic committee:

30 Gaotanyan Main Street, Shapingba District, Chongqing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

陆军军医大学

Primary sponsor:

Army Medical University

研究实施负责(组长)单位地址:

重庆市沙坪坝高滩岩正街30号陆军军医大学

Primary sponsor's address:

30 Gaotanyan Main Street, Shapingba District, Chongqing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军军医大学

具体地址:

沙坪坝区高滩岩正街30号

Institution
hospital:

Army Medical University

Address:

30 Gaotanyan Main Street, Shapingba District

经费或物资来源:

重庆市自然科学基金重点项目

Source(s) of funding:

Key projects of Chongqing Natural Science Foundation

研究疾病:

抑郁症  

Target disease:

depression

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究拟在抑郁症患者中应用基于慈心冥想的心理干预,并观察该方案是否可改变个体情绪调节能力,提升社会支持,降低抑郁水平。同时,我们拟观察干预方案对个体免疫功能以及对大脑奖赏环路结构和功能变化的影响,以探讨基于慈心冥想的心理干预对抑郁起作用的心理、生理、神经机制。  

Objectives of Study:

This study intends to apply psychological intervention based on compassionate meditation in patients with depression, and observe whether this program can change the individual's ability of emotional regulation, improve social support and reduce the level of depression. At the same time, we intend to observe the effects of intervention on individual immune function and on the structure and function of brain reward loop, in order to explore the psychological, physiological and neural mechanism of psychological intervention based on compassionate meditation on depression.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.酒精依赖、药物依赖;
2.双相障碍、合并其他类型严重精神疾病;
3.严重躯体疾病、外伤;
4.核磁禁忌症:幽闭恐惧症或体内有植入电子设备、金属者;
5.有严重自杀倾向者;
6.妊娠或哺乳期的妇女;
7.既往进行过任何形式的冥想训练。

Exclusion criteria:

1. Mental disorders caused by substance abuse (alcohol, drugs);
2. Bipolar disorder, combined with other types of severe mental illness;
3. Severe physical disease;
4. Nuclear magnetic contraindications: claustrophobia or people with implanted electronic devices or metal in the body;
5. Serious suicidal tendencies;
6. Pregnant or lactating women;
7. Have had any form of meditation training in the past.

研究实施时间:

Study execute time:

From 2021-03-03 00:00:00 To 2022-04-03 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-03-03 00:00:00 To 2021-04-03 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

30

Group:

Intervention group

Sample size:

干预措施:

基于慈心冥想的心理干预

干预措施代码:

Intervention:

Psychological intervention based on loving-kindness meditation

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

常规治疗

干预措施代码:

Intervention:

Treat as usual

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军军医大学 

单位级别:

三甲 

Institution
hospital:

Army Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

贝克抑郁量表第2版

指标类型:

主要指标

Outcome:

BDI-II

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

儿童期创伤问卷

指标类型:

次要指标

Outcome:

CTQ-SF

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

艾森克人格问卷

指标类型:

次要指标

Outcome:

EPQ

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

自我描述问卷

指标类型:

次要指标

Outcome:

Self-description Task

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

应付方式问卷

指标类型:

次要指标

Outcome:

Coping Style Questionnaire

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

社会支持评定量表

指标类型:

次要指标

Outcome:

Social Support Rating Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心理弹性量表

指标类型:

次要指标

Outcome:

CD-RISC

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活事件量表

指标类型:

次要指标

Outcome:

LES

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

五因素正念量表

指标类型:

主要指标

Outcome:

FFMQ

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

亲子依恋量表

指标类型:

次要指标

Outcome:

IPPA

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

亲子疏离问卷

指标类型:

次要指标

Outcome:

IAP

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

粪便

组织:

Sample Name:

fecal

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由项目负责人按照随机数字表法分组。

Randomization Procedure (please state who generates the random number sequence and by what method):

By the project leader according to random number table method grouping.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Not stated

Blinding:

Not stated

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

需要时咨询项目负责人 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Consult the study leader when needed

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2021-03-12 11:35:06